Anaphylaxis
Risk of severe allergic reaction. Seek urgent medical help if serious symptoms occur.
Medicine information ISOTREXIN GEL 0.5mg / 20mg / g
- Product code:
- W56787001
- Quantity:
- 1
- Indicated for:
- acne vulgaris
- Route of administration:
- cutaneous
- Substance:
- isotretinoin + erythromycin (retinoid+macrolide antibiotic)
- ATC
- D10AD54 — Dermatologicals | Anti-acne preparations | Anti-acne preparations for topical use | Retinoids for topical use in acne
The combination of isotretinoin and erythromycin is used to treat moderate to severe acne. Isotretinoin reduces sebum production and inflammation, while erythromycin is an antibiotic that targets bacteria associated with acne.
The medication is available as a gel or cream and is applied topically to affected areas, usually once or twice daily, as directed by a doctor.
Side effects may include local irritation, dryness, or redness of the skin. In rare cases, severe allergic reactions may occur.
Patients should avoid prolonged sun exposure and use sunscreen. Pregnant or breastfeeding women should consult a specialist before use.
The medication is available as a gel or cream and is applied topically to affected areas, usually once or twice daily, as directed by a doctor.
Side effects may include local irritation, dryness, or redness of the skin. In rare cases, severe allergic reactions may occur.
Patients should avoid prolonged sun exposure and use sunscreen. Pregnant or breastfeeding women should consult a specialist before use.
General data about ISOTREXIN GEL 0.5mg / 20mg / g
- Substance:
- isotretinoin + erythromycin
- Date of latest medicines list:
- 01-07-2021
- Product code:
- W56787001
- Strength:
- 0.5mg / 20mg / g
- Pharmaceutical form:
- gel
- Quantity:
- 1
- Product type:
- Generic medicine
- Prescription status:
- P-6L — Medicines dispensed with a medical prescription that is not retained by the pharmacy and may be renewed; the prescription may be used for 6 months from the date of issue.
Strengths available for isotretinoin + erythromycin
- 0.05%/0.2%
- 0.5mg/20mg/g
Official documents
Professional information (SmPC) - Romanian
Patient leaflet - Romanian
Packaging and labelling information - Romanian
The correspondence between the document and the displayed text is unconfirmed.
- Source institution
- ANMDMR
- Document language
- Romanian
Warnings:
Contraception required
Effective contraception is required during treatment.
Contraindicated during pregnancy
Do not use this medicine during pregnancy.
Photosensitivity
Avoid excessive exposure to sunlight or UV radiation.
Teratogenic / fetal risk
This medicine may affect fetal development.